CDK ASSOCIATES, L.L.C. 4
4 · Strongbridge Biopharma plc · Filed Dec 28, 2018
Insider Transaction Report
Form 4
CDK ASSOCIATES, L.L.C.
10% Owner
Transactions
- Purchase
Ordinary Shares, $0.01 par value
2018-12-26$4.00/sh+31,197$124,698→ 6,563,105 total - Purchase
Ordinary Shares, $0.01 par value
2018-12-27$3.98/sh+18,200$72,434→ 6,581,305 total
Footnotes (1)
- [F1]Following the transactions reported herein, these shares represent (a) 6,244,501 Ordinary Shares that are owned directly by CDK Associates, LLC, which is a reporting person, and may be deemed to be indirectly beneficially owned by (i) Caxton Corporation, the manager of CDK Associates, LLC, and (ii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation; and (b) 336,804 Ordinary Shares beneficially owned by employees of an affiliate of Caxton Corporation and may be deemed to be indirectly beneficially owned by (i) Caxton Corporation and (ii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation.